A concern for ophthalmic antibiotic resistance in Bangladesh
Md Nasir Ahmed, Mohammed Rahmatullah, Rownak Jahan, Chowdhury Alfi Afroze
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRetinal and Optic Conditions · Ocular Infections and Treatments · Ocular Diseases and Behçet’s Syndrome
In 2022, Bangladesh witnessed a sudden surge in conjunctivitis infections with some hospitals reporting three times the usual patient load with conjunctivitis [1]. According to media reports, conjunctivitis, characterized by red eyes, eye pain, and irritation, may have spiked in Bangladesh since July 2022 and reached its peak by September [2]. The outbreak of conjunctivitis has been reported mainly in Chattogram, Dhaka, Sylhet, Narayanganj and Faridpur regions [3].
Conjunctivitis in most cases is caused by viral infections. In the current outbreak, nearly half of these patients are infected with human adenovirus [1]. Bangladesh has noted an outbreak of conjunctivitis during the COVID‐19 pandemic with eye‐related manifestations such as red eye, itching, watering, vision loss, acute infection and inflammation [4, 6]. Earlier outbreaks of acute viral haemorrhagic conjunctivitis had also happened in 1981 caused by enterovirus 70 (EV 70) [7].
Viral infections and viral conjunctivitis do not need antibiotics unless there is an added bacterial infection. However, in the current outbreak, topical antibiotics such as Moxifloxacin, and Chloramphenicol are freely dispensed by pharmacy retailers without the prescription of health professionals [2]. In addition, there is also rampant use of Ciprofloxacin, Dexamethasone, and Natamycin for a viral eye infection [8]. These activities are a cause of concern in terms of antimicrobial stewardship and rising antimicrobial resistance of ocular pathogens such as Staphylococcus spp., coagulase‐negative staphylococci, methicillin‐resistant, and Haemophilus spp.) in recent decades has been a concern [9]. In 2017, a study of antibiotic susceptibility on bacteria collected from infected eyes in Bangladesh, Staphylococcus, Streptococcus, and Pseudomonas species were resistant to Gatifloxacin, Gentamicin, Tobramycin, Cloxacillin, Ciprofloxacin, Moxifloxacin, Cefixime, and Cephalexin [10]. An increase in ophthalmic antibiotic resistance may be a major problem when indicated in cataract surgery, corneal ulcers or bacterial eye infections.
Raising public awareness regarding the judicious use of ophthalmic antibiotics is essential to avoid unprecedented ophthalmic epidemics and antimicrobial resistance burden. Regulations for self‐medication, distribution, and selling antibiotics should include ophthalmic antibiotics. Bangladesh should initiate nationwide surveillance on antibiotic resistance in ocular microorganisms.
AUTHOR CONTRIBUTIONS
Visualization; resources; writing – original draft; project administration: Md Nasir Ahmed. Conceptualization; writing – review and editing; supervision: Mohammed Rahmatullah. Validation; writing – review and editing: Rownak Jahan. Investigation: Chowdhury Alfi Afroze.
CONFLICT OF INTEREST STATEMENT
The authors have declared no conflicts of interest.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1New Age . Conjunctivitis cases on rise. New Age | The Most Popular Outspoken English Daily in Bangladesh. n.d. Accessed November 12, 2022. https://www.newagebd.net/article/182757/conjunctivitis‐cases‐on‐rise
- 2The Business Standard . As conjunctivitis surges, doctors caution against needless use of antibiotic drops. The Business Standard. 2022. Accessed November 12, 2022. https://www.tbsnews.net/bangladesh/health/conjunctivitis‐surges‐doctors‐caution‐against‐needless‐use‐antibiotic‐drops‐506030
- 3Mokbul MI , Islam AMK , Tabassum MN , Nur FB , Sharmin S . Recent incidence of infectious conjunctivitis in Bangladesh: Are we aware? Ann Med Surg. 2022:104819. 10.1016/j.amsu.2022.104819 PMC 979311536582876 · doi ↗ · pubmed ↗
- 4Ahmed MS , Kabir MS , Bhuiyan MH . Covid‐19: Effects on eye in Bangladesh. Bangladesh Med J. 2020;49(2):14‐18. 10.3329/bmj.v 49i 2.55814 · doi ↗
- 5Islam SRU , Akther T , Mahfuzullah MA , et al. Detection of SARS‐Co V‐2 RNA in conjunctival swab of a COVID‐19 patient: the first report from Bangladesh. SAGE Open Med Case Rep. 2020;8:8. 10.1177/2050313 X 20964103 10.1177/2050313 X 20964103 PMC 882563535154766 · doi ↗ · pubmed ↗
- 6Ul Kadir SM , Moniruzzaman M , Rahman S , Nasa K , Ahmed T , Maurya RP . The impact of COVID‐19 on ophthalmic practice in Bangladesh – a cross‐sectional study. Indian J Clin Exp Ophthalmol. 2021;7(2):289‐292. 10.18231/j.ijceo.2021.059 · doi ↗
- 7Hossain MM , Glass RI , Khan MU , Huq F , Hierholzer JC . Outbreak of enterovirus 70 conjunctivitis in Bangladesh – 1981. Trans R Soc Trop Med Hyg;77(1983):217‐218. 10.1016/0035-9203(83)90075-5 6306874 · doi ↗ · pubmed ↗
- 8Sharifa S , Anwar P , Shahida P , Abdullah MA . Prevalence of eye disease and its treatment pattern in Bangladesh: a case study of Ispahani Islamia Eye Hospital. Pharmacologyonline. 2019;3:120‐133.